<DOC>
	<DOCNO>NCT01078753</DOCNO>
	<brief_summary>This multi-center , randomize , placebo-controlled , parallel-group , double-blind , dose-escalating clinical trial design assess efficacy safety desmopressin orally lyophilisate treatment nocturnal enuresis `` decreased nighttime urinary osmolality . ''</brief_summary>
	<brief_title>Study With Two Different Doses Desmopressin Orally Lyophilisate Tablet With Nocturnal Enuresis</brief_title>
	<detailed_description />
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Nocturnal Enuresis</mesh_term>
	<mesh_term>Deamino Arginine Vasopressin</mesh_term>
	<criteria>Diagnosed nocturnal enuresis reduce nighttime urinary osmolality Age 6 16 regardless gender Outpatient Had 10 wet night 14day baseline period least 4 wet night respective week Deemed healthy investigator Able agree comply fluidintake restriction clinical trial matter specify clinical trial protocol Consent pediatric patient 's legally acceptable representative Demonstrate understand clinical trial receive explanation correspond prospective subject 's intelligibility Show possibility nurse mother pregnant , become pregnant If drug medical therapy Desmopressin treat nocturnal enuresis : able discontinue treatment Suffer enuresis underlie disease Participated another clinical trial within six month precede consent Used intranasal Desmopressin past Presently undergo systemic antibiotic treatment , treatment antidiuretic drug affect urinary concentration , drug medical therapy overactive bladder Have anomaly disease may affect oral absorption drug product Hard get cooperation subject school refusal , punishment bullying Deemed investigator inappropriate participate trial Unable place waterintake restriction start two hour bedtime Evidence hepatic , renal , cardiac , pulmonary dysfunction</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>